The stock market took a battering anew on Tuesday, with all major indices registering steep losses as investors continued to digest President Donald Trump’s next tariff deadline that would slap China with a cumulative 104-percent tariff.
The tech-heavy Nasdaq registered the heaviest fall, down by 2.15 percent, followed by the S&P 500’s 1.57 percent decline, and the Dow Jones’ 0.84-percent drop.
Meanwhile, 10 companies—four of which were in the medical sector—bucked an overall market decline, booking modest gains during the session.
In this article, we listed the 10 well-performing names of Tuesday and detailed the reasons behind their gains.
To come up with the list, we considered only the stocks with $2 billion market capitalization and $5 million in trading volume.
Photo by George Morina on Pexels
10. Sandisk Corp. (NASDAQ:SNDK)
Sandisk grew its share prices for a second day on Tuesday, adding 2.76 percent to end at $32.35 apiece as investors cheered the launch of what it touted as the next-generation storage solutions.
At the 2025 NAB Show in Las Vegas, SNDK launched the new SanDisk PRO-CINEMA CFexpress Type A Card, designed to meet the demand of professional cinematographers and videographers.
The new storage product boasts transfer speeds of 1800MB/s and write speeds up to 1650MB/s, enabling faster turnaround from shoot to post-production, ideal for professionals working with 8K RAW video, high-frame-rate footage, and burst photography.
The PRO-CINEMA CFexpress is available in capacities up to 960GB.
In addition to the CFexpress, SNDK is set to launch two powerful flash drives this summer to cater to the needs of media and entertainment professionals requiring fast, flexible, and high-capacity portable storage.
9. Constellation Energy Corporation (NASDAQ:CEG)
Constellation Energy rose for a second day on Tuesday, adding 2.86 percent to end at $184.94 apiece as investors found the company a haven asset to mitigate risks from the ongoing economic uncertainties.
As one of the leading power producers in the US, CEG is set to benefit from the Trump administration’s plan to ramp up the energy sector to power the manufacturing and artificial intelligence industries.
Earlier this week, Energy Secretary Chris Wright said he envisioned AI data centers to co-locate facilities with power sources in a bid to support the expansion of the US AI industry.
“You’re going to co-locate power. You’re going to build a data center, and you’re going to build the power and resources to power it,” he said.
The department said it was looking to enable the construction of AI infrastructure by the end of the year and begin operations at data center sites by the end of 2027.
The DOE’s plan was aimed at addressing one of the largest challenges facing the energy sector: finding a sufficient supply of electricity to support the AI boom and ensure the US stays competitive with China.
8. Viking Holdings Ltd. (NYSE:VIK)
Viking Holdings rallied by 4.01 percent on Tuesday to finish at $35.51 apiece as investor sentiment was buoyed by announcements that it would soon launch a new ship—the first to be powered by hydrogen stored onboard for both propulsion and onboard electricity generation.
Called the Viking Libra, the vessel is now underway construction at the Fincantieri Ancona shipyard and is scheduled for delivery in late 2026.
The Viking Libra will have a gross tonnage of approximately 54,300 tons and a length of 239 meters and will be able to accommodate up to 998 guests in 499 staterooms.
The new ship marks a new state-of-the-art hydrogen propulsion system that, combined with advanced fuel cell technology, will be able to produce up to six megawatts of power, and will set a new benchmark for the industry’s decarbonization efforts.
Apart from Libra, Viking’s subsequent ocean ship, the “Viking Astrea,” which is also under construction and scheduled for delivery in 2027, will also be powered by hydrogen.
7. Carvana Co. (NYSE:CVNA)
Used car selling platform Carvana Co. grew its share prices by 5.03 percent on Tuesday to end at $176.32 apiece after earning a positive rating from a brokerage firm.
On Monday, JMP Securities reaffirmed its Outperform rating for CVNA and a price target of $340, given the company’s ongoing expansion efforts, which include the integration of ADESA sites as a key driver for its growth.
CVNA has been actively integrating ADESA’s physical auction sites into its operations. At present, it was able to successfully integrate six out of 56 ADESA locations.
In other news, CVNA said it was developing its eighth auction and reconditioning “mega site” in Phoenix, Arizona, as it aims to bolster its operations in the Southwest.
“The Phoenix area is home to our headquarters and a significant anchor for Carvana and ADESA operations, so we couldn’t be more excited to expand our local capabilities and team here,” said CVNA Senior Vice President for Inventory Brian Boyd. ”Bringing Carvana Inspection and Reconditioning Center capabilities to ADESA Phoenix will drive additional speed and selection for our local retail customers and an even more robust offering for our local wholesale customers while also creating new entry-level and skilled jobs in the Chandler community.”
6. UnitedHealth Group Incorporated (NYSE:UNH)
UnitedHealth Group saw its share prices surge by 5.41 percent on Tuesday to finish at $28.38 apiece as investors snapped up shares in the company following a promise from the US government that it would bolster Medicare Advantage payments to $25 billion next year.
The figure, a 5.06-percent increase, was more than double the 2.2 percent hike that the government proposed in January. The new figure signaled relief for a sector that was already reeling with steep medical costs.
The Centers for Medicare & Medicaid Services (CMS), which oversees Medicare and Medicaid health insurance programs, said that the rate change primarily takes into account additional data on the increased costs for the insurers, including fourth-quarter payment data.
In other news, the US Senate last week voted to confirm Dr. Mehmet Oz, the celebrity physician nominated by none other than President Donald Trump, to oversee Medicare and Medicaid.
5. CVS Health Corporation (NYSE:CVS)
CVS Health saw its share prices jump by 5.92 percent on Tuesday to finish at $67.63 apiece following the US government’s announcement that it would more than double payments for the Medicare Advantage plans to $25 billion by next year.
CVS, one of the Medicare-focused health insurance companies, is set to benefit from the government plan alongside peers in the sector that are reeling from steep medical costs.
In other news, CVS also raised its growth outlook for the year and named a new chief financial officer.
The pharmacy and health insurance giant now expects to meet or exceed its previously adjusted earnings per share of $5.75 to $6.
Meanwhile, CVS named former UPS CFO Brian Newman as its new CFO. He is set to assume the role on April 21, 2025.
The company also named Amy Compton-Phillips as its chief medical officer effective May 19. She recently served as chief physician executive for Press Ganey.
The management shakeup followed CVS’ change in CEO in October last year when veteran David Joyner took the helm.
4. Alignment Healthcare Inc. (NASDAQ:ALHC)
Alignment Healthcare grew its share prices by 6.34 percent on Tuesday to finish at $18.95 apiece as investors snapped up shares in the company on optimism that it would benefit from the US government’s plan to more than double Medicare payments next year. ALHC is a health insurance company that offers Medicare Advantage services.
Following the government’s announcement, analysts from Stifel raised their price target for ALHC to $23 from $18 previously while maintaining a Buy rating on the company’s stock. The new price target marked a 21.37-percent upside from ALHC’s closing price on Tuesday.
Based on its own analysis, Stifel said that ALHC gained a market share over the last two annual enrollment periods, benefitting from the decline in star ratings of its competitors as well as their shrinking margins which led to cutbacks in benefits and memberships.
3. Grab Holdings Ltd. (NASDAQ:GRAB)
Grab Holdings bounced back on Tuesday, adding 7.18 percent to its valuation to end at $3.73 apiece as investor sentiment was fueled by an investment firm’s positive rating for the company.
On Tuesday, Citi reaffirmed its Buy rating and a price target of $6.25 on GRAB shares. The new price represented a 67.56-percent upside from the company’s closing price on Tuesday.
According to Citi, its rating was based on GRAB’s product event GrabX 2025 in Singapore where its CEO, Anthony Tan, and Chief Product Officer Philipp Kandal, announced that the company was looking to embrace and integrate Artificial Intelligence into its operations, particularly to enhance its services for drivers and customers.
According to Citi, GRAB’s ongoing product innovation and proven track record of execution arms the company well to steer through market uncertainties.
2. Venture Global Inc. (NYSE:VG)
Venture Global snapped a five-day losing streak on Tuesday, adding 11.71 percent to close at $7.82 apiece as investors resorted to bargain-hunting to take advantage of its cheap valuation, shunning news of law firms initiating investigations into the company on possible equities violation.
In separate statements, law firms Portnoy, as well as Robbins Geller Rudman & Dowd, encouraged VG investors to lead as a plaintiff for a class action lawsuit over allegations that the company promoted its innovative and disruptive approach, claiming it was both scalable and repeatable, enabling the company to bring LNG to the global market faster and at a lower cost.
It also alleged that VG highlighted the development of five natural gas liquefaction and export projects near the Gulf of Mexico.
According to the lawsuit, “when the true details emerged, investors suffered financial losses.”
VG has yet to issue a statement regarding the allegations.
1. Aglion Health Inc. (NYSE:AGL)
Aglion jumped for a third straight day on Tuesday, adding another 26.12 percent to end at $5.36 apiece after Bernstein SocGen Group raised its outlook and price target for the company.
On Tuesday, Bernstein upgraded its outlook for AGL to Outperform from Market Perform previously, and gave the company a price target of $8.50, up from the $3.30 previously. The new target represented a 59-percent upside from AGL’s latest closing price.
“Our upgrade reflects our improved confidence in AGL’s turnaround plan and cash position,” Bernstein said. “Since then, we have received several data points that increase our confidence in the turnaround plan, thus lowering the risk of a capital rise.”
The upgrade also took into account earlier announcements that the US government would bolster its Medicare Advantage payments next year, which is more than double what it proposed in January.
According to Bernstein, AGL is now expected to perform “better than expected.”
While we acknowledge the potential of AGL as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than AGL but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
